Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vicor and MacroGenics and Encourages Investors to Contact the Firm

Group 1: Vicor Corporation (NASDAQ: VICR) - The class period for the Vicor Corporation lawsuit is from April 26, 2023, to February 22, 2024, with a lead plaintiff deadline of September 23, 2024 [2] - The complaint alleges that Vicor misled investors by falsely claiming a significant deal for its H100 product, which was believed to be with Nvidia Corporation [2] - Following the failure to discuss the deal on October 24, 2023, and a subsequent press release on February 22, 2024, Vicor's stock price fell approximately 60% from an intra-class period high of nearly $100 per share [2] Group 2: MacroGenics, Inc. (NASDAQ: MGNX) - The class period for the MacroGenics lawsuit is from March 7, 2024, to May 9, 2024, with a lead plaintiff deadline of September 24, 2024 [3] - On May 9, 2024, MacroGenics reported five fatal outcomes in its TAMARACK Phase 2 study, leading to a decline in share price by $11.36, or approximately 77.4%, from $14.67 to $3.31 [3] - The lawsuit claims that MacroGenics made material misrepresentations by providing overly positive statements while concealing adverse facts related to early interim safety data from the TAMARACK Phase 2 study [4]